Literature DB >> 28621340

Reproductive endocrinology: Elagolix in endometriosis.

Conor A Bradley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28621340     DOI： 10.1038/nrendo.2017.74

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  1 in total

1.  Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist.

Authors:  Hugh S Taylor; Linda C Giudice; Bruce A Lessey; Mauricio S Abrao; Jan Kotarski; David F Archer; Michael P Diamond; Eric Surrey; Neil P Johnson; Nelson B Watts; J Chris Gallagher; James A Simon; Bruce R Carr; W Paul Dmowski; Nicholas Leyland; Jean P Rowan; W Rachel Duan; Juki Ng; Brittany Schwefel; James W Thomas; Rita I Jain; Kristof Chwalisz
Journal:  N Engl J Med       Date:  2017-05-19       Impact factor: 91.245
  1 in total
  2 in total

Review 1.  Elagolix in the treatment of heavy menstrual bleeding associated with uterine fibroids in premenopausal women.

Authors:  Mohamed Ali; Sara A R; Ayman Al Hendy
Journal:  Expert Rev Clin Pharmacol       Date:  2021-03-15       Impact factor: 5.045

2.  NAT2 gene polymorphisms and endometriosis risk: A PRISMA-compliant meta-analysis.

Authors:  Zhangming Wei; Mengmeng Zhang; Xinyue Zhang; Mingyu Yi; Xiaomeng Xia; Xiaoling Fang
Journal:  PLoS One       Date:  2019-12-27       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.